Weller, T., et al “Fibrinogen receptor antagonists—a novel class of promising antithrombotics” Drugs of the Future, vol. 19, No. 5, pp. 461-476, 1994.* |
Hynes, R.O., “Integrins: Versatility, Modulation and Signaling in Cell Adhesion”, Cell 69:11 (1992). |
Yue, T.L., et al., “Osteopontin-Stimulated Vascular Smooth Muscle Cell Migration is Mediated by β3 Integrin”, Exp. Cell. Res. 214:459-464 (1994). |
Matsuno, H., “Inhibition of Integrin Function by A Cyclic RGD-Containing Peptide Prevents Neointima Formation”, Circulation 90:2203-2206 (1994). |
Rouslahti, E. and Pierschbacher, M.D., “New Perspectives in Cell Adhesion: RGD and Integrins”, Science 238:491-497 (1987). |
Coller, B.S., “Blockade of Platelet GPIIb/IIIa Receptors as an Antithrombotic Strategy”, Circulation 92:2373-2380 (1995). |
Pfaff, M., et al., “Selective Recognition of Cyclic RGD Peptides of NMR Defined Conformation by αIIββ3, αvβ3, and α5β1 Integrins”, J. Biol. Chem. 269:20233-20238 (1994). |